cholesterol drugs

Pharma News Briefs: Human Genome, Merck, Novartis

Here's a roundup of some of Wednesday's major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck's experimental heart drug appears to work well without side effects; and Novartis announced its plans for long-term growth.

FDA Warns Against High Doses of Zocor

The U.S. Food and Drug Administration issued a warning Friday about using high doses of the popular cholesterol-lowering drug Zocor -- generic name simvastatin -- and the increased risk of serious muscle injury.

Inside Wall Street: A Cholesterol Drug Could Be Big

If promising early results of its cholesterol-busting drug RVX-208 get supported in larger clinical trials, it could put this young company on the map in a big way. A partnership with a major drugmaker is a very strong possibility.